Celyad Oncology SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BE0974260896
EUR
0.18
0 (-1.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCelyad Oncology SA VS Pharmaceuticals & Biotechnology
 
1D
-1.1%
-0.14%
1W
2.86%
2.45%
1M
0%
6.46%
YTD
5.88%
8.65%
1Y
-57.35%
27.21%
3Y
-83.99%
41.88%
5Y
-97.32%
43.91%
10Y
-97.32%
66.91%
  • Stock Absolute Returns
  • Belgium BEL 20Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.0%
0%
-10.0%
6 Months
-54.55%
0%
-54.55%
1 Year
-57.35%
0%
-57.35%
2 Years
-53.0%
0%
-53.0%
3 Years
-83.99%
0%
-83.99%
4 Years
-94.32%
0%
-94.32%
5 Years
-97.32%
0%
-97.32%

Celyad Oncology SA for the last several years.

stock-summaryRisk Adjusted Returns v/s Belgium BEL 20
Risk Adjusted Returns v/s stock-summary